A case of type 1 diabetes mellitus with high titer anti-GAD antibody after combined interferon and ribavirin therapy for chronic C hepatitis

Journal of the Japan Diabetes Society

Volumn 50, Issue 10, 2007, Pages 753-757

  Watanabe, Jun ^a   Yamauchi, Teruaki ^a  

^a Department of Medicine

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38449114061     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bhaski H, Sriskandan K, Davis T, Pettingale K, Tee D (1985) Recombinant gamma interferon and autoimmune thyroid disease. Lancet 24:457
2. Fabris P, Betterle C, Floreani A, Greggio NA, de Lazzari F, Naccarato R, Chiaramonte M (1992) Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 14: 1236
3. Huang X, Yuan J, Goddard A, Foulis A, James RF, Lernmark A, Pujol-Borrell R, Rabinovitch A, Somoza N, Stewart TA(1995) Interferon-α expression in the pancreas of patients with type I diabetes. Diabetes 44 : 658-664
4. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ (1993) Induction of type 1 diabetes by interferon-α transgenic mice. Science 260 : 1942-1946
5. Klassen LW, Williams GW, Reinertsen JL, Gerber NL, Steinberg AD (1979) Ribavirin treatment in murine autoimmune disease I. Arthritis Rheum 22:145-154
6. Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C (2003) Review article : type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 18 : 549-558
7. Waguri M, Hanafusa T, Ito N, Imagawa A, Miyagawa J, Kawata S, Kono N, Kuwajima M, Matsuzawa Y (1994) Occurrence of IDDM during interferon therapy for chronic viral hepatitis. Diabetes Res Clin Pract 23 : 33-36
8. Japanese source
9. Japanese source
10. Japanese source
11. Japanese source
12. Shiba T, Morino Y (1995) Onset of diabetes with high titer anti-GAD antibody after interferon therapy for chronic hepatitis. Diabetes Res Clin Pract 30:237-241
13. Japanese source
14. Japanese source
15. Japanese source
16. Kado S, Miyamoto J, Komatsu N, Iwaki Y, Ozaki H, Taguchi H, Kure M, Sarashina G, Watanabe T, Katsura Y, Nemoto Y, Noritake M, Matsuoka T (2000) Type 1 diabetes mellitus caused by treatment with interferon-beta. Intern Med 39:146-149
17. Uto H, Matsuoka H, Murata M, Okamoto T, Miyata Y, Hori T, Ido A, Hirono S, Hyashi K, Tsubouchi H (2000) A case of chronic hepatitis C developing insulindependent diabetes mellitus associated with various antibodies during interferon therapy. Diabetes Res Clin Pract 49:101-106
18. Japanese source
19. Japanese source
20. Japanese source
21. Nakanishi K, Kobayashi T, Murase T, Kakatsuji T, Inoko H, Tsuji K, Kosaka K (1993) Association of HLAA24 with complete beta-cell destruction in IDDM. Diabetes 42:1086-1093
22. Kabbaj N, Guedira MM, El Atmani H, Mohammadi M, Benabed K, Lachkar H, Benabed K, Lachkar H, Benaissa A (2006) Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C : a prospective cohort study. Ann Endocrinol 67:343-347